Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-064683

Karyopharm Therapeutics Inc. · KPTI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Sharon Shacham
Officer — President & CSO
Period of report
Dec 7, 2017
Accepted (ET)
Dec 8, 2017 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001503802

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Dec 7, 2017M10,000$0.264A723,510D
Common StockF3Dec 7, 2017S10,000$10.3903D713,510D
Common StockF4holding———512,143IBy Spouse
Common StockF5holding———47,309IBy GRAT
Common StockF6holding———47,309IBy Spouse's GRAT

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F7$0.264Dec 7, 2017M10,000D—Dec 13, 2021Common Stock10,00029,394D

Explanation of responses